Piramal board approves demerger of pharma business
The Hindu
The Board of Directors of Piramal Enterprises Ltd (PEL) on Thursday approved a composite scheme of arrangement providing for the demerger of the pharmaceuticals business and simplification of the comp
The Board of Directors of Piramal Enterprises Ltd (PEL) on Thursday approved a composite scheme of arrangement providing for the demerger of the pharmaceuticals business and simplification of the company’s corporate structure.
As per the decision the pharmaceuticals business will get vertically demerged from PEL and be consolidated under Piramal Pharma Ltd (PPL). Post the demerger, PPL will become one of the large pharma companies listed on NSE and BSE.
More Related News